While the mechanism of CRNDE’s action in endothelial cells is unknown, CRNDE has the potential to be a novel target in the fight against the angiogenic complications of diabetes and obesity. This evidence concerns the gene CRNDE and obesity due to melanocortin 4 receptor deficiency.